Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2000
09/06/2000EP1032688A1 Single-chain bifunctional glycoprotein hormones
09/06/2000EP1032687A2 Human cdnas encoding polypeptides having kinase functions
09/06/2000EP1032682A1 Desaturase genes and their use
09/06/2000EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION
09/06/2000EP1032674A2 $i(CHLAMYDIA PNEUMONIAE) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION
09/06/2000EP1032672A1 Dna19355 polypeptide, a tumor necrosis factor homolog
09/06/2000EP1032671A1 Mammalian cytokine-like polypeptide-10
09/06/2000EP1032670A1 Toso
09/06/2000EP1032668A1 Fibroblast growth factor-19
09/06/2000EP1032667A2 A33-related antigens and their pharmacological uses
09/06/2000EP1032666A1 A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
09/06/2000EP1032665A1 A human 2-19 protein homologue, z219c
09/06/2000EP1032662A1 Methods and compositions for immunomodulation
09/06/2000EP1032661A1 Apo-2DcR
09/06/2000EP1032660A1 Method of identifying binding site domains that retain the capacity of binding to an epitop
09/06/2000EP1032649A1 deoD
09/06/2000EP1032597A1 Methods for detection of prion protein as an indication of transmissible spongiform encephalopathies
09/06/2000EP1032595A2 Nucleic acids involved in the responder phenotype and applications thereof
09/06/2000EP1032591A1 NOVEL pth
09/06/2000EP1032582A1 NOVEL recJ
09/06/2000EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
09/06/2000EP1032422A1 Linear antigen supporting units
09/06/2000EP1032421A1 Monoclonal human natural antibodies
09/06/2000EP1032420A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
09/06/2000EP0809806A4 Monoclonal antibodies for human osteogenic cell surface antigens
09/06/2000EP0770089B1 Growth differentiation factor-12
09/06/2000EP0504388B1 Varicella-zoster virus antigen
09/06/2000CN1265666A Oxidized styrenic polymer for DNA binding
09/06/2000CN1265425A New human triphosphatase protein and its code sequence
09/06/2000CN1265424A Diene cryl coenzyme reductase as one new kind of human peroxidase and its code sequence
09/06/2000CN1056186C Monoclonal antibody against human manganese-superoxide dismutase, method for producing them and use
09/06/2000CN1056084C Immunotoxins directed against CD33 related surface antigens
09/05/2000US6114598 Generation of xenogeneic antibodies
09/05/2000US6114516 Nucleotide sequences coding for variable regions of the αchains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic muses
09/05/2000US6114515 PIGRL-1, a member of immunoglobulin gene superfamily
09/05/2000US6114508 Cocaethylene immunogens and antibodies
09/05/2000US6114507 A neutralizing antibody that supresses ligand induced apoptosis; therapy of hepatitis b, hepatitis c, human immunodeficiency virus infections
09/05/2000US6114506 Composition and method for enhancing fibrinolysis
09/05/2000US6114323 Diabetic kidney disease; administering aminoguanidine
09/05/2000US6114308 Inhibitors of trypsin-like enzymes
09/05/2000US6114160 Polynucleotide which codes for polypeptide of defined amino acid sequence which has taxadiene synthase activity; for recombinant production especially higher than normal gene expression in escherichia coli
09/05/2000US6114147 Immobilizing protein by modifying a fungus to produce a chimeric protein composed of a binding protein, a secretory signal peptide, and an anchoring portion; producing protein; transporting to cell wall; for separating target compounds
09/05/2000US6114143 Anti-HIV monoclonal antibody
09/05/2000US6114140 Nucleotide sequences that code protein with enzymatic activity; for detecting proteins which bind hydrolase enzymes; antiproliferative agents; anticarcinogenic agents
09/05/2000US6114133 Detection of nervous system disorder by monitoring amino acid sequence fragments in cerebrospinal fluid and contrasting with standard
09/05/2000US6114124 Detection of APC proteins
09/05/2000US6113914 Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
09/05/2000US6113903 Antidiabetic agents
09/05/2000US6113902 Polypeptides with amino acid sequences of pro-lys-ile and cyclic epitopes
09/05/2000US6113901 Immunopotentiating cd-3 antigen monoclonal antibodies
09/05/2000US6113900 Use of IL-2 receptor-targeted therapeutics to inhibit allograft rejection and treat autoimmune disorders
09/05/2000US6113899 Antagonists of chaperonin 10
09/05/2000US6113898 Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
09/05/2000US6113897 Antibodies and their use
09/05/2000US6113629 Hydrogel for the therapeutic treatment of aneurysms
09/05/2000CA2057058C Monoclonal antibodies to c-reactive protein
09/05/2000CA1341094C Diagnosis for malignant hyperthermia
08/2000
08/31/2000WO2000050900A2 Methods and compositions for diagnosing carcinomas
08/31/2000WO2000050607A2 Goodpasture antigen binding protein
08/31/2000WO2000050597A2 Neutrokine-alpha and neutrokine-alpha splice variant
08/31/2000WO2000050596A2 14273 receptor, a novel g-protein coupled receptor
08/31/2000WO2000050590A1 Mdm interacting protein and methods of use thereof
08/31/2000WO2000050580A2 Composition, methods and reagents for the synthesis of a soluble form of human phex
08/31/2000WO2000050566A2 Genes encoding insect odorant receptors and uses thereof
08/31/2000WO2000050565A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
08/31/2000WO2000050562A2 Dna encoding snorf25 receptor
08/31/2000WO2000050461A1 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
08/31/2000WO2000050460A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
08/31/2000WO2000050457A1 Prostate-specific membrane antigens and methods of making and using
08/31/2000WO2000050453A1 A novel inhibitor of programmed cell death
08/31/2000WO2000050450A1 Mite protein
08/31/2000WO2000050081A1 Product and method for treatment of conditions associated with receptor-desensitization
08/31/2000WO2000050079A1 Tumor necrosis factor antagonists for the treatment of neurological disorders
08/31/2000WO2000050077A1 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
08/31/2000WO2000050070A2 Preparation for the treatment of pigmentation disorders
08/31/2000WO2000050062A2 Methods and compositions for altering mucus secretion
08/31/2000WO2000050061A1 Detecting the expression of the desc1 gene in squamous cell carcinoma
08/31/2000WO2000028029A3 Cell surface glycoproteins
08/31/2000WO2000027410A3 Composition and method for increasing weight gain and feed efficiency
08/31/2000WO2000025805A8 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2
08/31/2000WO2000018923A9 Slgp protein and nucleic acid molecule and uses therefor
08/31/2000WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
08/31/2000WO2000018803A3 Antibodies to mammalian langerhans cell antigen and their uses
08/31/2000WO2000018795A9 Compositions and methods for wt1 specific immunotherapy
08/31/2000WO2000009657A3 Methods of modulating of angiogenesis
08/31/2000DE19908242A1 Composition for treating pigmentation disorders, e.g. vitiligo, containing the protein DCoH, or related nucleic acids, antibodies or antisera
08/31/2000CA2369433A1 Methods and compositions for diagnosing carcinomas
08/31/2000CA2366951A1 Methods and compositions for altering mucus secretion
08/31/2000CA2364966A1 Genes encoding insect odorant receptors and uses thereof
08/31/2000CA2364160A1 Product and method for treatment of conditions associated with receptor-desensitization
08/31/2000CA2364130A1 Tumor necrosis factor antagonists for the treatment of neurological disorders
08/31/2000CA2363794A1 14273 receptor, a novel g-protein coupled receptor
08/31/2000CA2363641A1 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
08/31/2000CA2363637A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
08/31/2000CA2363621A1 A novel inhibitor of programmed cell death
08/31/2000CA2363118A1 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
08/31/2000CA2363112A1 Neutrokine-alpha and neutrokine-alpha splice variant
08/31/2000CA2363106A1 Mdm interacting protein and methods of use thereof
08/31/2000CA2362906A1 Dna encoding snorf25 receptor
08/31/2000CA2361396A1 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
1 ... 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 ... 1494